CIK: 1506314 - Address: C/O Novavax, Inc., 700 Quince Orchard Road, Gaithersburg, MD 20878
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1110-7-16-21-24-27-19
P%wins1000000017
S%ret115-3-3-447102
S%wins100606060507568

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/12/24 20:46
3/10/24
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKelly James PatrickMDOEVP,CFO,M.d00.00055313D
3/11/24 21:39
3/7/24
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKelly James PatrickMDOEVP,CFO,M.d00.0001211D
8/18/23 16:37
8/16/23
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKelly James PatrickMDOEVP,CFO,M.d00.00021075D
3/14/23 17:19
3/10/23
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKelly James PatrickMDOEVP,CFO,M.d306.52053D
8/18/22 17:02
8/16/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKelly James PatrickMDOEVP,CFO,M.d00.00021D
3/4/20 17:01
3/2/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOEVP,CFOS.m-19510.360-19-9187D
1/6/20 17:25
1/2/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOEVP,CFOS-6415.940-4-2206D
3/4/19 17:06
3/1/19
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOEVP,CFOS.m-27419.980-14-6210D
1/4/19 16:33
1/2/19
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOEVP,CFOS.m-16026.370-6-3193D
3/2/18 17:34
3/1/18
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOEVP,CFOS.d-16018.720-9-4200D
1/4/18 17:12
1/2/18
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOEVP,CFOM.d00.0001812168D
1/4/18 17:12
1/2/18
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOEVP,CFOS.d-14015.350-9-5168D
1/5/17 17:01
1/3/17
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,M.d00.008204070D117637-2-7-14-1-3-11-13-15
1/5/17 17:01
1/3/17
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,S.d-16915.518-11-1470D117637-2-7-14-1-3-11-13-15
1/6/16 19:09
1/4/16
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,M.d00.008173961D-28-37-27-25-65-6-6-441-13380
1/6/16 19:09
1/4/16
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,S.d-868.968-10-1461D-28-37-27-25-65-6-6-441-13380
3/12/15 18:53
3/10/15
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,M.d00.0011258553D187-30-16-12-7-6-310-6-82419-26
3/12/15 18:53
3/10/15
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,S.d-13110.5311-12-1953D187-30-16-12-7-6-310-6-82419-26
2/20/14 16:39
2/18/14
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,M.d00.0019209041D18623723-8101018021032-30-7-18
11/21/13 20:00
11/19/13
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,S-4012.0733-3-1029D120254636156271-20-8-5-823-130
7/31/13 16:32
7/29/13
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,M.d00.00994132D6418016613963329413-5-1-30526
2/19/13 20:38
2/14/13
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickDCOSVP,CFO,M.d00.0011730723D-47-17-2265-800-2-5-365164241
2/21/12 18:00
2/16/12
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickMDOSVP,CFO,M.d00.00113999%13D-56-35-13-113-4-11-2047-12-10-14
2/21/12 18:00
2/16/12
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickMDOSVP,CFO,S.d-234.671-5-2813D-56-35-13-113-4-11-2047-12-10-14
8/30/11 16:31
8/29/11
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsKelly James PatrickMDOSVP,CFO,P305.9915New5D-57-5-19-20-16011120-7-16-21-24-27

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact